Key highlights

  • Ansell Ltd (ASX:ANN) shares touched a 52-week high during the 19 October 2026 session and closed at $46.35, up 0.39%.
  • The FY26 results release dated 24 August 2026 reports sales of US$2,140.2 million and adjusted EPS of US148.6 cents.
  • A final Dividend of US41.5 cents was determined, and FY27 adjusted EPS is guided to a range of US158 to US170 cents.

Ansell Ltd (ASX:ANN) is a global safety solutions company that makes personal protection equipment for healthcare and industrial workplaces. The shares touched a 52-week high during the Trading session on 19 October 2026 and closed at $46.35, up 0.39%. In an ASX announcement dated 24 August 2026, the company released its full-year results for the year ended 30 June 2026, together with dividend details, a share repurchase update and FY27 guidance.

FY26 headline results

All amounts in the release are in US dollars. Sales were $2,140.2 million, up 6.8% on FY25 and up 5.0% on an organic constant-currency basis, or 5.7% after excluding sales that benefitted from temporary order patterns. Adjusted EBIT was $321.9 million, up 14.1%, with the adjusted EBIT Margin rising to 15.0% from 14.1%. Statutory EBIT was $320.5 million, compared with $183.9 million.

Adjusted net profit after tax was $212.3 million, up 15.8%, and statutory net profit after tax was $208.6 million, compared with $101.6 million. Adjusted EPS was US148.6 cents, up from US126.1 cents, and includes a net benefit of US3.3 cents from non-recurring items. Operating Cash Flow was $270.1 million, compared with $105.4 million, and cash conversion was 113%.

Segments, tariffs and cost programs

The Industrial segment, 44% of segment sales, reported sales of $947.3 million, up 3.3% organically, and adjusted EBIT of $170.6 million. The Healthcare segment, 56% of segment sales, reported sales of $1,192.9 million, up 6.4% organically, and adjusted EBIT of $170.7 million, up 23.5% organically. The release says cleanroom sales rose 10.0% on an adjusted basis, and that US sales grew 10% on an adjusted basis.

Ansell says sourcing changes and price increases offset higher US tariffs and cost Inflation linked to the Middle East crisis. It has applied for refunds of tariffs paid before the February US Supreme Court ruling, with about $12 million received in July and the timing of the remaining recovery described as uncertain. The Accelerated Productivity Investment Program has reached its $50 million recurring pre-tax savings target, with one-off cash costs expected to total $85 million to $90 million, of which $69 million had been incurred to date. ERP system upgrades are planned to start in North America in FY27.

Dividend, share repurchase and balance sheet

A final unfranked dividend of US41.5 cents per share was determined at a 50% payout ratio, bringing the full-year dividend to US68.1 cents at a 45% payout ratio. The Record Date was 1 September 2026 and the payment date 17 September 2026. The company completed $118.4 million of its $200 million on-market share repurchase in FY26 and will continue the program in FY27. Net Debt to adjusted EBITDA was 1.3 times, net debt fell by $52.3 million, and Liquidity was $752 million in cash and undrawn facilities.

FY27 outlook

FY27 adjusted EPS is expected in a range of US158 cents to US170 cents. The company assumes a foreign exchange benefit of about $9 million, net interest cost of about $43 million, a tax rate of 23.5% to 24.5%, one-off pre-tax costs of about $15 million, and Capital Expenditure of $45 million to $55 million. The Annual General Meeting is scheduled for 9 November 2026.

Sector backdrop

The S&P/ASX 200 (ASX: XJO) stood at 8,845.70 at 4:25 pm (GMT+11) on 19 October 2026, up 0.44%, or 39.00 points, for the day. On the sector map, Industrials rose 0.93% and Health Care fell 0.13%, the two groups most closely tied to Ansell’s segments. On the sector map for the session, Energy rose 2.16%, Industrials 0.93%, Financials 0.85%, Utilities 0.38% and Consumer Staples 0.25%, while Information Technology fell 1.35%, A-REIT 0.34%, Consumer Discretionary 0.18%, Telecommunication Services 0.16% and Health Care 0.13%. One further segment, left unlabelled on the map, rose 0.11%.

The Ansell results release is dated 24 August 2026, almost two months before the 19 October session, so this article does not link the two.

Risks shareholders should weigh

The release states that global macroeconomic conditions remain uncertain and that Ansell stays ready to adjust prices if Tariff rates or the cost environment change. The timing and size of further US tariff refunds are uncertain. Second-half Healthcare sales included about $15 million of customer stocking ahead of price increases, a timing effect that does not necessarily repeat.

Currency movements and hedge contracts affected earnings, with a net foreign exchange loss of $13.8 million on hedges in FY26 and an overall unfavourable effect of $4.3 million on EBIT. The FY27 guidance excludes the effect of the share repurchase and relies on assumptions about exchange rates, interest costs and tax. Program costs, including ERP implementation, continue into FY27.

What’s next

The release lists the FY27 EPS range, continued execution of the $200 million share repurchase, the start of ERP upgrades in North America, ongoing price adjustments as costs change and the 9 November 2026 AGM. Future results will be reported on the usual ASX timetable.